Fig. 4
From: Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

Survival curves for molecular glioblastoma based on (a) MET, (b) MDM2 and (c) EGFR amplification status
From: Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
Survival curves for molecular glioblastoma based on (a) MET, (b) MDM2 and (c) EGFR amplification status